Cite
Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].
MLA
Zhu, Yu, et al. “Corrigendum to ‘Oridonin Regulates the Polarized State of Kupffer Cells to Alleviate Nonalcoholic Fatty Liver Disease through ROS-NF-ΚB’ [Int. Immunopharmacol. 101(Part B) (2021) 108290].” International Immunopharmacology, vol. 119, June 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2023.110302.
APA
Zhu, Y., Ruan, S., Shen, H., Guan, Q., Zhai, L., & Yang, Y. (2023). Corrigendum to “Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB” [Int. Immunopharmacol. 101(Part B) (2021) 108290]. International Immunopharmacology, 119, N.PAG. https://doi.org/10.1016/j.intimp.2023.110302
Chicago
Zhu, Yu, Shuiliang Ruan, Heping Shen, Qiaobing Guan, Liping Zhai, and Yi Yang. 2023. “Corrigendum to ‘Oridonin Regulates the Polarized State of Kupffer Cells to Alleviate Nonalcoholic Fatty Liver Disease through ROS-NF-ΚB’ [Int. Immunopharmacol. 101(Part B) (2021) 108290].” International Immunopharmacology 119 (June): N.PAG. doi:10.1016/j.intimp.2023.110302.